Aptevo Therapeutics
APVO
APVO
6 hedge funds and large institutions have $35.9K invested in Aptevo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
1
Birchview Capital
Burlington,
Vermont
|
$30.5K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BC
1
Birchview Capital
Burlington,
Vermont
| $30.5K | 10,000 | +10,000 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $3.64K | 1,192 | -2,063 | -63% |
|
|
SS
3
SBI Securities
Tokyo,
Japan
| $1.79K | 588 | -113 | -16% |
|
4
Bank of America
Charlotte,
North Carolina
| $9 | 3 | -2,315 | -100% |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $4 | 1 | – | – |
|
6
BlackRock
New York
| $3 | 1 | -23 | -96% |
|
7
Geode Capital Management
Boston,
Massachusetts
| – | – | -10,526 | Closed |
|
|
CS
8
Clear Street
New York
| – | – | -2,800 | Closed |
|
9
Morgan Stanley
New York
| – | – | -4 | Closed |
|